N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
Abstract:
The present disclosure provides immunogenic compositions comprising the N-domain of carcinoembryonic antigen (CEA). These compositions are useful for inducing or enhancing an immune response, for inhibiting tumor cell growth and for treating cancer.
Information query
Patent Agency Ranking
0/0